Select a Meeting...

Meetings Archive For Hospital Medicine 2017, May 1-4, 2017; Las Vegas, Nev...

Abstract Number: 77
LONG-TERM CLINICAL AND ECONOMIC OUTCOMES OF INTENSIVE VS STANDARD BLOOD PRESSURE REDUCTION IN NON-DIABETICS AT HIGH CARDIOVASCULAR RISK – EXTRAPOLATIONS FROM THE SPRINT TRIAL
Hospital Medicine 2017, May 1-4, 2017; Las Vegas, Nev.
Background: Results from the recent SPRINT trial demonstrate lower rates of fatal and non-fatal major cardiovascular events and all-cause mortality in non-diabetics at high cardiovascular risk with intensive versus standard treatment, i.e., less than 120 versus less than 140 mmHg systolic, respectively. However, the long-term outcomes remain unknown.Methods: A validated state-transition model with multivariate risk [...]
Abstract Number: 78
PRIOR STATIN USE MIGHT BE ASSOCIATED WITH LOWER SEPSIS MORTALITY – RESULTS FROM A “BIG DATA” STUDY
Hospital Medicine 2017, May 1-4, 2017; Las Vegas, Nev.
Background: The randomized controlled ANZ-STATInS trial demonstrated that de novo statin use did not alter interleukin-6 levels or Sequential Organ Failure Assessment (SOFA) score in of what before SEPSIS-3 was known as severe sepsis. Prospective observational studies indicate that prior statin use sepsis is associated with a decreased rate of severe sepsis. We aimed to [...]
Abstract Number: 79
TRENDS IN INCIDENCE AND LIABILITY COSTS FROM DIAGNOSTIC ERROR IN INPATIENT SETTINGS: INSIGHTS FROM THE NATIONAL PRACTITIONER DATA BANK
Hospital Medicine 2017, May 1-4, 2017; Las Vegas, Nev.
Background: Although diagnostic errors are common in hospitals, little is known about the resulting economic burden. Whether the increasing attention to patient safety has led to a decrease in diagnostic error-related claims and cost over time is also unknown. Using a publicly available dataset, we examined incidence costs and outcomes associated with diagnostic errors in [...]
Abstract Number: 80
IDENTIFYING GAPS IN CARE OF MALNOURISHED PATIENTS AND THE EFFECTS ON LENGTH OF STAY AND READMISSION IN AN ACUTE CARE SETTING
Hospital Medicine 2017, May 1-4, 2017; Las Vegas, Nev.
Background: Malnourished patients compose 25% to 54% of the admitted patient population. Much attention has been given to identifying these malnourished patients. However, few published articles have focused on identifying the gaps in care that follow a malnutrition diagnosis and their effects on length of stay and readmission. We aimed to describe the prevalence of [...]
Abstract Number: 81
IMPACT OF ADMISSION URINE CULTURE ON ANTIBIOTIC USE AND HOSPTIAL LENGTH OF STAY
Hospital Medicine 2017, May 1-4, 2017; Las Vegas, Nev.
Background: Overuse of urine testing may result in downstream events that impact antibiotic use and hospital length of stay (LOS). The aims of this study were to examine the impact of inpatient urine culture testing on inpatient antibiotic use and hospital length of stay using a national administrative dataset. Methods: We performed a retrospective cohort [...]
Abstract Number: 82
BURDEN OF 30-DAY READMISSIONS FOLLOWING HOSPITALIZATION FOR PNEUMONIA IN YOUNG AND MIDDLE-AGED ADULTS
Hospital Medicine 2017, May 1-4, 2017; Las Vegas, Nev.
Background: While pattern of readmissions in young survivors of acute myocardial infarction and heart failure has been described, burden of 30-day readmissions following hospitalization for pneumonia in young adults is poorly understood. Further, gender differences in readmission rates are unknown. Methods: We examined the 2013 Nationwide Readmission Database (NRD), a nationally representative all-payer database of [...]
Abstract Number: 83
PREVALENCE OF CHEMOPREVENTIVE AGENT USE AMONG HOSPITALIZED WOMEN AT HIGH RISK FOR BREAST CANCER: A CROSS-SECTIONAL STUDY
Hospital Medicine 2017, May 1-4, 2017; Las Vegas, Nev.
Background: Approximately 15% of women in the United States aged 35-79 year are at high risk for developing breast cancer, however less than 0.2% of these women reported taking chemoprevention to reduce their risk. Objective of the study was to characterize the current utilization of chemoprevention agents among hospitalized women who are at higher risk [...]
Abstract Number: 84
ANTIMOTILITY USE IN PATIENTS WITH C DIFFICILE–POTENTIALLY SAFE?
Hospital Medicine 2017, May 1-4, 2017; Las Vegas, Nev.
Title: ANTI-MOTILITY USE IN PATIENTS WITH C. DIFFICILE –POTENTIALLY SAFE? Background: Anti-motility agents have typically been avoided in patients with Clostridium difficile diarrheal infections (CDI) due to fear of gastrointestinal complications such as toxic mega-colon.  However, severe diarrhea, such as chemotherapy-related diarrhea, can result in significant adverse consequences to patients, such as volume loss and [...]
Abstract Number: 85
IMPACTS OF ANXIOLYTIC MEDICATION TYPE ON INTENSIVE CARE UNIT LENGTH OF STAY
Hospital Medicine 2017, May 1-4, 2017; Las Vegas, Nev.
Background: Mechanically ventilated patients are often administered analgesic medications such as dexmedetomidine (DEX) and lorazepam (LZP) to reduce pain and anxiety. Studies have suggested that benzodiazepines may increase the risk of developing acute brain dysfunction, mechanical ventilation time, and length of stay (LOS) (Pandharipande PP, et al. JAMA 2007). Although Clinical Practice Guidelines recommend use [...]
Abstract Number: 86
MISSING THE YELLOW FLAGS: DOES A TARDY RESPONSE TRIGGER THE RAPID RESPONSE?
Hospital Medicine 2017, May 1-4, 2017; Las Vegas, Nev.
Background: A Rapid Response (RR) Team is activated when there is an acute change in a patient’s condition. Rapid responses are called when certain criteria are met. A delay in activation of the rapid response or non-activation of the rapid response can be associated with increased morbidity and mortality. Goal 16 of the Joint Commission’s [...]